The Corporate Practice: A Dermatology Giant Comes for Bellingham's Local Clinic

BELLINGHAM, WA – June 15, 2026 – On the surface, the announcement was standard corporate fare: Fairhaven Dermatology, a respected local practice founded by Bellingham native Dr. Thomas Langei, was joining Epiphany Dermatology, a rapidly expanding national network. The press release spoke of “shared values,” “additional resources,” and a “commitment to improving access.”

But behind the polished language lies a story that is becoming emblematic of a fundamental restructuring of American healthcare. This is not just about one clinic in the Pacific Northwest. It’s about the quiet, relentless march of corporate consolidation into the most personal of spaces: the doctor’s office. The partnership between Fairhaven and Epiphany brings a national trend, supercharged by private equity, directly to the doorstep of a community that prides itself on local identity.

The Epiphany Blueprint: Growth Fueled by Private Equity

To understand what’s happening in Bellingham, one must first look to Austin, Texas. Epiphany Dermatology, co-founded in 2014 by CEO Gheorghe Pusta, is a case study in aggressive, strategic growth. The company’s stated mission is to improve access to dermatologic care, particularly in underserved markets. Its method is acquisition.

Fueled by the immense financial backing of its owner, the private equity behemoth Leonard Green & Partners—a firm with over $50 billion in assets under management—Epiphany has expanded at a blistering pace. In just the last few years, it has more than doubled in size, growing from 67 locations in 2022 to the 129 locations it boasts today. The partnership with Fairhaven marks its inaugural entry into Washington state.

The model is both simple and potent. Epiphany targets successful, established local practices and offers them a deal that is increasingly hard to refuse. In exchange for ownership, the parent company takes over the administrative burdens that plague independent physicians: operations, marketing, compliance, IT, and the labyrinthine world of managed care contracts. As the press release notes, Dr. Langei and his staff will now gain access to this robust corporate support system.

“This partnership reflects our shared values and commitment to clinical excellence,” Epiphany’s CEO Gheorghe Pusta stated in the announcement, highlighting a message of collaboration. The pitch is one of synergy: Epiphany handles the business, allowing physicians to retain “clinical autonomy” and focus purely on patient care. It’s a compelling narrative that has successfully brought dozens of independent practices into its fold.

A Changing Landscape in Bellingham

Back in Bellingham, Fairhaven Dermatology was not a practice in crisis. Founded in 2016 by Dr. Thomas Langei, it had built a sterling reputation. Dr. Langei, a Bellingham native who returned to his hometown after extensive training, is a highly respected, fellowship-trained Mohs surgeon with over 18,000 skin cancer removal surgeries to his name. Patient reviews consistently praise his skill, his team’s friendliness, and the personalized care they provide. He is precisely the kind of community-rooted professional that patients seek out.

“My team and I are excited to join Epiphany,” Dr. Langei said in the release, echoing the sentiment of shared commitment to patient care. For many physicians, the allure of shedding administrative duties to focus on medicine is powerful.

However, the context in Bellingham is crucial. This is not an instance of a large corporation rescuing a struggling practice in an underserved area. The Bellingham market is already competitive. Another major player, Frontier Dermatology—a large, physician-owned group in the Pacific Northwest—also has a significant presence here. In fact, Frontier recently expanded its own Bellingham footprint in late 2024 by acquiring another local practice. Epiphany’s arrival signals an escalation, transforming the local market into a new front for competition between large, well-funded healthcare networks.

This raises critical questions for the community. The promise of “improved access” is a core tenet of Epiphany’s mission. But will the corporate drive for efficiency and scale translate into shorter wait times and better care, or will it lead to changes in insurance network acceptance, service offerings, and the potential loss of the personal touch that defined Fairhaven Dermatology?

The Doctor Will Be Acquired Now

Zooming out from Bellingham reveals a systemic shift. The Epiphany-Fairhaven partnership is a microcosm of the nationwide consolidation of specialty medical practices, a trend overwhelmingly driven by private equity investment. Dermatology, with its mix of essential medical services and lucrative cosmetic procedures, has become a particularly attractive target. The U.S. dermatology market, valued at nearly $1.6 billion in 2026, is projected to surge to $2.15 billion by 2030.

Private equity firms are not healthcare providers; they are investors seeking returns. Their thesis is that by acquiring and consolidating small practices, they can create economies of scale, increase negotiating power with suppliers and insurers, and optimize operations for profitability. Proponents argue this model brings much-needed capital and business acumen to medicine, allowing practices to invest in new technology and free doctors from burnout.

But critics and healthcare watchdogs worry about the downstream effects on the relationship between citizen and state, patient and provider. “The model promises clinical autonomy, but the pressure to meet corporate metrics is always there, even if it’s subtle,” noted one healthcare industry analyst familiar with similar acquisitions. “That can manifest as pressure to increase patient volume, up-sell elective services, or standardize care in ways that may not suit every individual.”

The transaction is more than a business deal; it represents a change in the very structure of how care is delivered. For years, residents went to Dr. Langei's clinic. Now, they will go to Epiphany Dermatology, location #129 in a portfolio managed from an office in Austin. While the familiar faces in the exam room may remain, the invisible systems holding the practice together—its financial incentives, its operational priorities, its ultimate allegiance—have fundamentally changed. The Bellingham community will now serve as a test case, and its residents will be the ultimate judges of whether this new, consolidated structure reinforces the quality of local care or reveals the first signs of fraying.